全球泌尿支架市场 - 市场规模（依细分市场）、占有率、监管、偿付、程序、预测（~2033）

尿路结石症是一种尿液中的化学物质沉淀并形成固体物体（称为肾结石）的疾病。肾结石形成后，可能留在肾臟或沿着尿路进入输尿管。肾结石由多种物质形成，包括草酸盐、尿酸、鸟粪石和胱氨酸。尿路结石和良性前列腺增生（BPH）治疗方法的不断增加，特别是那些需要支架置入或反覆支架置入的治疗，是泌尿支架市场的主要成长动力。

本报告研究和分析了全球泌尿支架市场，提供了有关主要参与者和市场占有率、主要趋势、创新产品和技术以及竞争格局的资讯。

市场模型的主要内容如下。

尿路支架已经上市以及不断变化的竞争格局

• 对主要产业趋势的考察
• 依细分市场划分的泌尿支架市场年收入与市场前景（2015-2033年）
• 有关单位数量、平均售价和市场价值的市场级资料

全球、区域和国家层面的特定市场考察

• 依地区细分全球趋势的特定市场定性资讯和国家考察
• 泌尿支架市场SWOT分析
• 泌尿支架市场竞争动态思考及趋势

掌握包括医疗保健系统概述真实情况，促进市场了解。市场进入部分还提供有关偿付政策和监管环境的讯息，能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 依国家/地区划分的偿付政策
• 各国医疗科技监理状况

目标公司

• Boston Scientific Corp
• Cook Medical Inc
• CR Bard Inc
• Olympus Corp
• Coloplast A/S
• Applied Medical Resources Corporation
• Allium Medical Solutions Ltd
• Pnn Medical A/S
• SRS Medical Systems Inc

Urinary Tract Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Nephrology and Urology Devices therapeutic area.

A urinary tract stent is a small tube, made of either metal or polymer material, that is inserted into the urinary tract to keep it open. These tubular devices, composed of polymers or metal, are placed in the urinary tract or ureter to treat or prevent blockages that hinder urine flow from the kidney to the bladder.

Urolithiasis is a condition in which chemicals found in urine precipitate to form a solid object known as a kidney stone. After formation, the stone may stay in the kidney or travel down in the urinary tract into the ureter. Kidney stones may be formed from several materials including oxalic acid, uric acid, struvite, or cystine.The increasing number of treatments for Urolithiasis and Benign Prostatic Hyperplasia (BPH), especially requiring stent placement and recurrent stenting, has been identified as the primary growth driver for the urinary tract stents market.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Urinary Tract Stents and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Urinary Tract Stents market revenue by segment and market outlooks from 2015 - 2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Urinary Tract Stents market.
• Competitive dynamics insights and trends provided for Urinary Tract Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Cook Medical Inc, CR Bard Inc, Olympus Corp, Coloplast A/S, Applied Medical Resources Corporation, Allium Medical Solutions Ltd, Pnn Medical A/S, SRS Medical Systems Inc

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Urinary Tract Stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Urinary Tract Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Urinary Tract Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Urinary Tract Stents market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.